ORTEXORTEX News
Tracking FRBT? Get live short interest, options flow, and signals on ORTEX.Sign up free →
FR
Trader NoteFRBT

Forbright Gains 7% on Earnings Day as Shorts Cover and Street Stays Bullish

By ORTEX News · Edited by , Editor, ORTEX News3 min readdata as of 30 Oct 2026, 17:28

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

FRBT reported third-quarter earnings Thursday, and the market's response was unambiguous: the stock closed up 6.9% on the day to $18.43, capping a 7.3% weekly gain and extending a steady one-month climb of 7.8%.

The borrow market tells a story of retreating pressure rather than fresh conviction. Short interest has fallen 38% over the past week to roughly 177,000 shares, a rapid unwind from levels above 326,000 in mid-October. Cost to borrow remains elevated at 18.3%, but that is down sharply from 28% in late September and a recent peak above 27% in early October. Availability is generous at nearly 600% of short interest, meaning there are roughly six shares available to lend for every one already borrowed. That is well above the 52-week tightest reading of 74.5%, confirming this is not a supply-constrained borrow. The pattern across October looks like a short squeeze unwind: positions built through mid-month, borrowing costs rose to their highest level of the period, and then the stock moved against them sharply around the earnings print.

The Street had largely positioned itself bullishly ahead of results. All three covering analysts who have filed updates in 2026 hold Overweight or Buy ratings. Barclays lifted its target to $24 earlier this month, and JP Morgan upgraded from Neutral to Overweight on October 1, cutting its target only modestly to $22. Wells Fargo held its Overweight but trimmed to $21. The consensus mean target of $22.75 implies about 23% upside from Thursday's close, which is meaningful for a small-cap bank valued at roughly $936 million. Valuation multiples have moved in lock-step with the price: the price-to-book ratio has expanded modestly over the past month, but at 0.83x the stock still trades below book, an unusual discount for a bank whose total assets have risen for nine consecutive quarters. The earnings-yield multiple at 0.11 remains modest, reflecting the market's still-cautious tone toward community and growth-oriented bank franchises.

The FDIC call reports tracked by ORTEX Alt Data paint a consistent picture of balance sheet expansion. Total assets reached $8.48 billion as of the April 2026 quarter, and net loans and leases have grown for eight straight quarters to $6.05 billion. The dataset has not been in ORTEX's system long enough to establish a statistically measured lead against Forbright's reported figures, so it cannot be used as a forward indicator. What it does confirm is an unbroken organic growth streak heading into the Q3 print.

Ownership is concentrated and largely anchored. The top three institutional holders, Gallatin Point Capital, Centerbridge Partners and Bayview Asset Management, collectively control more than half the company. Wellington Management filed a 13G in August disclosing a 9% passive stake. None of the filings on record are Schedule 13D activist disclosures. Insider activity in recent weeks has been routine: several directors received small stock awards around mid-October at $17.39, consistent with board compensation mechanics rather than discretionary buying. The Sachs offsetting award and disposal entries in October and August cancel each other and carry no directional signal. It is worth noting that Forbright was added to the Russell 2000 at the September 2026 quarterly rebalance, generating an estimated $71 million in index-tracker buying over roughly 21 days of normal volume. That forced demand has now been absorbed.

The next scheduled earnings event is not until April 2027, leaving a long gap before the next hard catalyst. What to watch in the interim is whether the analyst community updates targets above $22 in response to Thursday's print, and whether the short base, now down to its lowest level in two months, stabilises or continues to shrink.

Stocks in this article

See the live data behind this article on ORTEX.

Open FRBT on ORTEX →

How this article was generated

Generated
30 Oct 2026, 17:33
Data as of
30 Oct 2026, 17:28
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationEarningsInstitutional positioningRecent ORTEX notesAlt DataIndex Rebalance

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.